
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Kole T. Roybal, Jasper Z. Williams, Leonardo Morsut, et al.
Cell (2016) Vol. 167, Iss. 2, pp. 419-432.e16
Open Access | Times Cited: 584
Kole T. Roybal, Jasper Z. Williams, Leonardo Morsut, et al.
Cell (2016) Vol. 167, Iss. 2, pp. 419-432.e16
Open Access | Times Cited: 584
Showing 26-50 of 584 citing articles:
T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
Robert Sackstein, Tobias Schatton, Steven R. Barthel
Laboratory Investigation (2017) Vol. 97, Iss. 6, pp. 669-697
Open Access | Times Cited: 193
Robert Sackstein, Tobias Schatton, Steven R. Barthel
Laboratory Investigation (2017) Vol. 97, Iss. 6, pp. 669-697
Open Access | Times Cited: 193
Organ‐on‐a‐Chip for Cancer and Immune Organs Modeling
Wujin Sun, Zhimin Luo, Junmin Lee, et al.
Advanced Healthcare Materials (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 192
Wujin Sun, Zhimin Luo, Junmin Lee, et al.
Advanced Healthcare Materials (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 192
Strategies to Address Chimeric Antigen Receptor Tonic Signaling
Adam Ajina, John Maher
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 9, pp. 1795-1815
Open Access | Times Cited: 191
Adam Ajina, John Maher
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 9, pp. 1795-1815
Open Access | Times Cited: 191
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M. Jaffee, Chi V. Dang, David B. Agus, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 11, pp. e653-e706
Open Access | Times Cited: 180
Elizabeth M. Jaffee, Chi V. Dang, David B. Agus, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 11, pp. e653-e706
Open Access | Times Cited: 180
Making CAR T Cells a Solid Option for Solid Tumors
Andrea Schmidts, Marcela V. Maus
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 177
Andrea Schmidts, Marcela V. Maus
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 177
Mechanisms of Notch signaling: a simple logic deployed in time and space
Domingos Henrique, François Schweisguth
Development (2019) Vol. 146, Iss. 3
Open Access | Times Cited: 175
Domingos Henrique, François Schweisguth
Development (2019) Vol. 146, Iss. 3
Open Access | Times Cited: 175
Gene editing for immune cell therapies
Stefanie R. Bailey, Marcela V. Maus
Nature Biotechnology (2019) Vol. 37, Iss. 12, pp. 1425-1434
Closed Access | Times Cited: 172
Stefanie R. Bailey, Marcela V. Maus
Nature Biotechnology (2019) Vol. 37, Iss. 12, pp. 1425-1434
Closed Access | Times Cited: 172
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 170
Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 170
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Axel Hyrenius‐Wittsten, Su Yang, Minhee Park, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 591
Open Access | Times Cited: 167
Axel Hyrenius‐Wittsten, Su Yang, Minhee Park, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 591
Open Access | Times Cited: 167
Biophysics of Notch Signaling
David Sprinzak, Stephen C. Blacklow
Annual Review of Biophysics (2021) Vol. 50, Iss. 1, pp. 157-189
Open Access | Times Cited: 160
David Sprinzak, Stephen C. Blacklow
Annual Review of Biophysics (2021) Vol. 50, Iss. 1, pp. 157-189
Open Access | Times Cited: 160
CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions
Bradley D. Hunter, Caron A. Jacobson
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 7, pp. 646-654
Open Access | Times Cited: 156
Bradley D. Hunter, Caron A. Jacobson
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 7, pp. 646-654
Open Access | Times Cited: 156
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Stefan Stoiber, Bruno L. Cadilha, Mohamed-Reda Benmebarek, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 472-472
Open Access | Times Cited: 153
Stefan Stoiber, Bruno L. Cadilha, Mohamed-Reda Benmebarek, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 472-472
Open Access | Times Cited: 153
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
Kedar Kirtane, Hany Elmariah, Christine H. Chung, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002723-e002723
Open Access | Times Cited: 146
Kedar Kirtane, Hany Elmariah, Christine H. Chung, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002723-e002723
Open Access | Times Cited: 146
Co-opting signalling molecules enables logic-gated control of CAR T cells
Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh, et al.
Nature (2023) Vol. 615, Iss. 7952, pp. 507-516
Open Access | Times Cited: 145
Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh, et al.
Nature (2023) Vol. 615, Iss. 7952, pp. 507-516
Open Access | Times Cited: 145
Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
Tseng Hsiang-Chi, Wei Xiong, Saiaditya Badeti, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 143
Tseng Hsiang-Chi, Wei Xiong, Saiaditya Badeti, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 143
T cell circuits that sense antigen density with an ultrasensitive threshold
Rogelio A. Hernández‐López, Wei Yu, Katelyn A. Cabral, et al.
Science (2021) Vol. 371, Iss. 6534, pp. 1166-1171
Open Access | Times Cited: 143
Rogelio A. Hernández‐López, Wei Yu, Katelyn A. Cabral, et al.
Science (2021) Vol. 371, Iss. 6534, pp. 1166-1171
Open Access | Times Cited: 143
Control of the activity of CAR-T cells within tumours via focused ultrasound
Yiqian Wu, Yahan Liu, Ziliang Huang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1336-1347
Open Access | Times Cited: 143
Yiqian Wu, Yahan Liu, Ziliang Huang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1336-1347
Open Access | Times Cited: 143
Modular design of synthetic receptors for programmed gene regulation in cell therapies
Iowis Zhu, Raymond Liu, Julie Garcia, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1431-1443.e16
Open Access | Times Cited: 128
Iowis Zhu, Raymond Liu, Julie Garcia, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1431-1443.e16
Open Access | Times Cited: 128
The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function
Lexus R. Johnson, Daniel Y. Lee, Jacqueline S. Eacret, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4981-4995.e14
Open Access | Times Cited: 126
Lexus R. Johnson, Daniel Y. Lee, Jacqueline S. Eacret, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4981-4995.e14
Open Access | Times Cited: 126
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 121
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 121
Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 119
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 119
Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 111
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 111
Emerging principles of cytokine pharmacology and therapeutics
Robert A. Saxton, Caleb R. Glassman, K. Christopher García
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 21-37
Open Access | Times Cited: 110
Robert A. Saxton, Caleb R. Glassman, K. Christopher García
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 21-37
Open Access | Times Cited: 110
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 104
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 104
Strategies for monitoring cell–cell interactions
Tyler J. Bechtel, Tamara Reyes Robles, Olugbeminiyi Fadeyi, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 6, pp. 641-652
Closed Access | Times Cited: 103
Tyler J. Bechtel, Tamara Reyes Robles, Olugbeminiyi Fadeyi, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 6, pp. 641-652
Closed Access | Times Cited: 103